European public procurement and grants data from official registers · Data as of 17 November 2026; updated daily.

Tenders

Hormonal drug tenders in Spain

Hormonal drug tenders in Spain: 159 listed on GranTender since 2024. The median awarded contract value is about €12,000 (180 contracts with a stated value). Buyers with the most tenders: Gerencia de Atención Primaria del Area de Salud de Tenerife (37), Consejería de la Presidencia de la Junta de Castilla y León (17) and Hospital Universitario de Getafe (15); suppliers with the most contract awards: MERCK, S.L. (23), Curium Pharma Spain, S.A. (19) and Sanofi Aventis, S.A. (14). Sources: PLACSP, Registre públic de contractes de Catalunya (RPC) — Catalan public contracts register, open data (Generalitat) and TED. In 2025 the median contract value was €12,000; 91% of contracts drew a single bid (1.1 bids on average). Data as of 17 November 2026; updated daily.

Tenders
159
Open tenders
0
Awards
191
Awarded value awarded
€30,228,216
Awarded value contract
€1,974,706
Awarded value framework ceiling
€16
Median contract value awarded
≈ €12,000
Median contract value contract
≈ €77,000
Average bids per contract
1.9
Tenders in 2025
53 -9% on 2024

Median: contracts with a stated value, rounded. Average bids: contracts where the number of bids is published.

Value kinds: awarded — the value in the award decision; contract — the value of the signed or amended contract; paid — the amount actually paid; framework ceiling — the maximum of a framework agreement, given with every winner, not money spent. Different kinds are never added together.

Open tenders

No records yet.

Latest tenders

TenderBuyerEstimated valueStatusPublished
Suministro de medicamentos para el Servicio de Farmacia del Hospital Universitario de Ceuta, mediante contrato basadoGerencia de Atención Sanitaria del Instituto Nacional de Gestión Sanitaria en Ceuta€152,741Awarded13 November 2026
Suministro de medicamentos con acción farmacológica anticonceptivas con destino al Servicio de Farmacia de Madrid Salud (5 lotes)Organismo Autónomo Madrid Salud€1,284,725Closed7 September 2026
Expediente administrativo de contratación derivada del Acuerdo Marco nº 23/S/24/SU/DG/A/AM02 para la contratacion del suministro de medicamentos de uso humano de fabricación indusrial que contiene como principio activo la Somatropina (HGH), con destino al Hospital Universitario Doctor Jose Molina Orosa, mediante adhesion al Acuerdo Marco referenciado y tramitacion ordinaria.Gerencia de Atención Primaria del Area de Salud de Tenerife€228,000Awarded5 August 2026
Expediente administrativo de contratación derivada del Acuerdo Marco nº 23/S/24/SU/DG/A/AM02 para la contratacion del suministro de medicamentos de uso humano de fabricación indusrial que contiene como principio activo la Somatropina (HGH), con destino al Hospital Universitario Doctor Jose Molina Orosa, mediante adhesion al Acuerdo Marco referenciado y tramitacion ordinaria.Gerencia de Atención Primaria del Area de Salud de Tenerife€228,000Awarded5 August 2026
Segundo contrato basado en el Acuerdo Marco para el suministro respetuoso con el medio ambiente de medicamentos biológicos con biosimilares para varias Comunidades Autónomas, Centros del INGESA de Ceuta y Melilla y Organismos de la Administración General del Estado (Lote 6: Somatropina)Servicio Cántabro de Salud€2,454,750Awarded1 July 2026
Suministro de medicamentos con acción farmacológica anticonceptiva, con destino al Servicio de Farmacia de Madrid Salud (5 lotes)Organismo Autónomo Madrid Salud€1,284,725Closed30 June 2026
Suministro por precio unitario de Etonogestrel 68 mg. Implante subcutáneo para los centros dependientes de la Gerencia de AtenciónPrimaria del Área de Salud de Gran Canaria a la entidad ORGANON SALUD, S.L.Gerencia de Atención Primaria del Area de Salud de Tenerife€153,000Awarded19 June 2026
Suministro de Monodosis de hmdp-tc, dtpa, dmsa-tc, mag-3, y mibi-tc para Medicina Nuclear para el Hospital Universitario de GetafeHospital Universitario de Getafe€142,025Awarded16 June 2026
PASPC A/SUM-004672/20026 Suministro de monodosis de nanocoloides de albúmina,macroagregado, hmpao y tetrocyd para Medicina NuclearHospital Universitario de Getafe€138,386Awarded8 June 2026
Suministro de monodosis de pertecnetato sodico y tetroformina para medicina nuclearHospital Universitario de Getafe€138,754Awarded26 May 2026
medicamento_ anticonceptivos reversibles de larga duracion LARCSServicio de Salud - Servicios Centrales€1,402,351Awarded20 May 2026
Suministro de anticonceptivos reversibles de larga duración LARCSServicio de Salud - Servicios Centrales—Awarded20 May 2026
Suministro del medicamento Somatropina-Omnitrope (BIOLÓGICOS BIOSIMILARES) con destino a la Gerencia de Asistencia Sanitaria de Soria. Es un procedimiento Derivado Acuerdo Marco de INGESA del 2025/034. LOTE 6.Gerencia de Asistencia Sanitaria de Soria€78,329Awarded13 May 2026
Suministro de Radiofármacos para Medicina NuclearHospital Universitario de Getafe—Awarded5 May 2026
Suministro, respetuoso con el medio ambiente, de medicamentos biológicos con biosimilares (lote 6 - Somatropina), material de consumo ordinario necesario para prestar una adecuada atención sanitaria a los pacientes del Área de SaludGerencia de Asistencia Sanitaria del Bierzo€76,806Awarded15 April 2026
Adquisición de radiofármacos, de Curium con destino al Servicio de Medicina Nuclear (Unidad de radiofarmacia) , del Hospital Universitario Ramón y CajalHospital Universitario Ramón y Cajal€3,780,500Awarded14 April 2026
Adquisición de radiofármaco de Curium con destino al Servicio de Medicina Nuclear ( Unidad de Radiofarmacia) del Hospital Universitario Ramón y CajalHospital Universitario Ramón y Cajal€630,082Awarded31 March 2026
Suministro de medicamentos biológicos con biosimilares basados en diversos principios activos para el Hospitales Universitario “Obispo Polanco” de TeruelGerencia Sector Sanitario de Zaragoza 2€133,515Awarded16 March 2026
Primer contrato basado en el Acuerdo Marco para el suministro, respetuoso con el medio ambiente, de medicamentos biológicos con biosimilares para varias Comunidades Autónomas, centros del INGESA en Ceuta y Melilla y Organismos de la Administración General del Estado (Lote 6: Somatropina)Servicio Cántabro de Salud€436,602Awarded5 March 2026
Suministro de especialidades farmacéuticas biológicos con biosimilares con destino a las instituciones sanitarias del Sector HuescaGerencia Sector Sanitario de Zaragoza 2€53,898Awarded20 January 2026

Competition and prices

In 2025, half of the contracts were worth between €1,500 and €120,000, with a median of €12,000 (50 contracts with a stated awarded value). Contracts drew 1.1 bids on average (median 1) and 91% drew a single bid — based on 22 contracts with a known number of bids. Compared with 2024, in 2025 the median value rose 56% and the share of single-bid contracts rose from 62% to 91%. The usual procedures: open procedure (50%), direct award (38%), negotiation without a call for competition (5%) — of 128 tenders with a stated procedure.

The most contracts went to MERCK, S.L. (23), Curium Pharma Spain, S.A. (19) and Sanofi Aventis, S.A. (14) — together 29% of all contracts.

YearContractsMedian valueMiddle half of valuesBids on averageSingle bid
202471€7,700€430 – €150,0001.962% (34)
202553€12,000€1,500 – €120,0001.191% (22)
2026 (so far)55€15,000€5,800 – €110,0002.452% (31)
All years190€12,000€920 – €120,0001.965% (89)

Values: contracts with a stated value in EUR, each value kind on its own (awarded or contract value), approximate (±3 %). Bids: contracts of procedures with competition whose number of bids the source publishes (1–100 bids); the sources publish it for some contracts only (TED ≈ 3 in 4, Spain all, Poland about half, Italy few), so each figure states its base and is shown from 20 contracts. A contract counts in the year of its award (else of its tender). Figures as of 13 November 2026, recomputed every week.

Where you have a chance

Since 1 November 2024, 58% of the 65 contracts with a known number of bids had a single bid; the median was 1 bid. The number of bids is known for 65 of the 81 contracts from procedures with competition.

Buyers who often get few offers

The buyers below usually received one or two offers per contract — an offer from you would stand out.

In the last 12 months, 0 companies won their first contract in our records here — 0% of the 50 contracts (our records start on 1 January 2024).

Contracts awarded since 1 November 2024 (the last 24 months). Bids as the source publishes them, 1 to 100 per contract, in procedures with competition only (a direct award has one offer by design). As of 13 November 2026.

Main CPV divisions

CPV codes of this topic

  • 33640000 Medicinal products for the genitourinary system and hormones

A tender belongs here when its main CPV code starts with one of these codes; a tender without a usable CPV code (or with a general one) is matched by words of its title. A tender may belong to up to three topics.

Hormonal drugs and contraceptives in neighbouring countries

Today, 1 tender in the same niche is open in neighbouring countries.

Public tenders in the EU and the EEA are open to companies from every EU and EEA country on the same terms as local ones, and to companies from countries with a procurement agreement with the EU (such as Switzerland, the United Kingdom and Ukraine) for the contracts it covers. Open means the deadline has not passed (today's date). Neighbours: countries with a land border, a fixed link or a short sea crossing.

Expected soon3

ExpectedBuyerWhatWhy we expect itConfidence
now – Mar 2027
contract ends
Servicio Murciano de Salud - GerenciaHormonal drugs and contraceptives
Suministro de medicamentos con principios activos Levonorgestrel 1,5 mg comprimido y Ulipristal 30 mg comprimido.
Typical value: ≈ €110,000
The current contract with TEVA PHARMA SLU ends on 22 April 2027 (from its stated duration); no new tender has been published yet.
Earlier tenders: 11/2025
high
now – Mar 2027
contract ends
Servicio Gallego de SaludHormonal drugs and contraceptives
Suministro sucesivo de folitropina alfa
Typical value: ≈ €880,000
The current contract with GEDEON RICHTER IBERICA SAU ends on 1 April 2027 (from its stated duration); no new tender has been published yet.
Earlier tenders: 12/2024
high
Apr – Sep 2027
contract ends
Gerencia de Asistencia Sanitaria de SoriaHormonal drugs and contraceptives
Suministro del medicamento Somatropina-Omnitrope (BIOLÓGICOS BIOSIMILARES) con destino a la Gerencia de Asistencia Sanitaria de Soria. Es un procedimiento Derivado Acuerdo Marco de INGESA del 2025/034. LOTE 6.
Typical value: ≈ €71,000
The current contract with Sandoz Farmaceutica ends on 22 October 2027 (from its stated duration); no new tender has been published yet.
Earlier tenders: 05/2026
high

Forecast from public data, not an announcement. Methodology.

Market reports

Hormonal drugs and contraceptives by city

Hormonal drugs and contraceptives in other countries

Hormonal drugs and contraceptives across Europe

Topics in Health, medical equipment and medicines

Questions and answers

Where can I find hormonal drug tenders in Spain?
GranTender lists them in one place, from PLACSP, Registre públic de contractes de Catalunya (RPC) — Catalan public contracts register, open data (Generalitat) and TED, with their buyers, winners and contract values. Search in one country at a time (the first 5 results) is free; search across all countries at once, full result lists, saved keywords with an e-mail once a week and exports come with a plan.
Who wins the most hormonal drug tenders in Spain?
By number of contracts won: MERCK, S.L. (23), Curium Pharma Spain, S.A. (19), Sanofi Aventis, S.A. (14).
Which buyers publish the most hormonal drug tenders in Spain?
By number of tenders: Gerencia de Atención Primaria del Area de Salud de Tenerife (37), Consejería de la Presidencia de la Junta de Castilla y León (17), Hospital Universitario de Getafe (15).
Which CPV codes belong to “Hormonal drugs and contraceptives”?
33640000 Medicinal products for the genitourinary system and hormones; plus tenders without a usable CPV code whose title names the topic.
How many bids do hormonal drug tenders in Spain receive on average?
In 2025, contracts drew 1.1 bids on average (median 1) and 91% drew a single bid — based on 22 contracts with a known number of bids.
How much are contracts for hormonal drug tenders in Spain worth?
In 2025, half of the contracts were worth between €1,500 and €120,000, with a median of €12,000 (50 contracts with a stated awarded value). Compared with 2024, in 2025 the median value rose 56% and the share of single-bid contracts rose from 62% to 91%.
Which procedures are used for hormonal drug tenders in Spain?
The usual procedures: open procedure (50%), direct award (38%), negotiation without a call for competition (5%) — of 128 tenders with a stated procedure.
Which buyers get few offers in hormonal drug tenders in Spain?
Since 1 November 2024, these buyers usually received one or two offers per contract: Gerencia de Atención Primaria del Area de Salud de Tenerife (median 1 bid over 17 contracts), Hospital Universitario de Getafe (median 1 bid over 9 contracts) and Gerencia de Asistencia Sanitaria de Soria (median 1 bid over 5 contracts). Since 1 November 2024, 58% of the 65 contracts with a known number of bids had a single bid; the median was 1 bid.

CPV 2008 (Regulation (EC) No 213/2008), © European Union, Publications Office — via the eForms SDK, CC BY 4.0.